Literature DB >> 24597603

Status epilepticus in the immature rodent brain alters the dynamics of autophagy.

Alexander Philipp Benz, Jerôme Niquet, Claude Guy Wasterlain, Abdelhaq Rami1.   

Abstract

There is considerable interest in defining the molecular pathways involved in seizure-induced neuronal death. Necrotic, apoptotic and anti-apoptotic signalling pathways are activated after status epilepticus (SE). Analyses of apoptosis and necrosis have been merely reported, however conditions of autophagic cell death with hallmarks of type 2 programmed cell death-morphology are relatively few. Autophagy is a highly regulated cellular mechanism for the bulk degradation of cytoplasmic contents which is involved in a variety of physiological and pathological conditions associated with neurological diseases. Our goal was to examine whether autophagy is implicated in the cell death machinery after SE. For this purpose, we used lithium-pilocarpine model of SE in 14-day-old rats and examined the dynamics in the expression of autophagic markers in the hippocampus in controls and in animals subjected to SE at 6, 24, and 48h after the insult. Protein levels of central components of the autophagic machinery were dramatically affected by SE with, however, altered dynamics, compared to controls. Levels of LC3, phospho-mTOR/mTOR, BAG3 and Hsp70 were significantly increased, whereas Beclin 1 levels remained unchanged after SE. The dynamics in the expression of Atg3, Atg5, Atg7, Atg14 and LAMP1 were slightly altered. The amount of SQSTM1/p62 underwent a dramatic and highly significant breakdown 48 h after the induction of SE. These results demonstrate for the first time that SE in the immature brain results in significant alterations of autophagy dynamics. There is a growing interest in the role of autophagy in neurodegeneration, and an emerging consensus that autophagy represents a double-edged sword, acting either as a prosurvival mechanism, or as part of a cell death pathway.

Entities:  

Mesh:

Year:  2014        PMID: 24597603     DOI: 10.2174/1567202611666140305215009

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  6 in total

Review 1.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

2.  Recombinant Human Erythropoietin Protects Against Hippocampal Damage in Developing Rats with Seizures by Modulating Autophagy via the S6 Protein in a Time-Dependent Manner.

Authors:  Qinrui Li; Ying Han; Junbao Du; Hongfang Jin; Jing Zhang; Manman Niu; Jiong Qin
Journal:  Neurochem Res       Date:  2017-12-13       Impact factor: 3.996

3.  Axonal Accumulation of Lysosomal-Associated Membrane Protein 1 (LAMP1) Accompanying Alterations of Autophagy Dynamics in the Rat Hippocampus Upon Seizure-Induced Injury.

Authors:  A Rami; A P Benz; J Niquet; A Langhagen
Journal:  Neurochem Res       Date:  2015-09-02       Impact factor: 3.996

4.  Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure.

Authors:  Mahshid Hosseinzadeh; Sara Nikseresht; Fariba Khodagholi; Nima Naderi; Nader Maghsoudi
Journal:  J Mol Neurosci       Date:  2016-01-06       Impact factor: 3.444

5.  IL-33 Provides Neuroprotection through Suppressing Apoptotic, Autophagic and NF-κB-Mediated Inflammatory Pathways in a Rat Model of Recurrent Neonatal Seizure.

Authors:  Yuan Gao; Cheng-Liang Luo; Li-Li Li; Guang-Hua Ye; Cheng Gao; Hao-Chen Wang; Wen-Wen Huang; Tao Wang; Zu-Feng Wang; Hong Ni; Xi-Ping Chen; Lu-Yang Tao
Journal:  Front Mol Neurosci       Date:  2017-12-19       Impact factor: 5.639

Review 6.  Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation.

Authors:  Nina D Anfinogenova; Mark T Quinn; Igor A Schepetkin; Dmitriy N Atochin
Journal:  Cells       Date:  2020-10-24       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.